Try our Advanced Search for more refined results
April 23, 2004
In Re: Oxycontin Antitrust Litigation
Case Number:
1:04-md-01603
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Epstein Drangel
- Goodwin Procter
- Axinn Veltrop
- Kaplan Fox
- Finnegan
- Rakoczy Molino
- Klehr Harrison
- Shuman Glenn
- Dewsnup King
- Jones Day
- Boies Schiller
- Paul Weiss
- Pomerantz LLP
- Zwerling Schachter
- Venable LLP
- Cohen Milstein
- Joseph Saveri Law Firm
- Morrison Mahoney
- Robins Kaplan
- McDonald Hopkins
- Odom & Des Roches
- Faruqi & Faruqi
- Porter Wright
- Schnader Harrison
- Crowell & Moring
- Ropes & Gray
- Motley Rice
- Covington & Burling
- Giaccio LLC
- Fish & Richardson
- Cozen O'Connor
- Lowenstein Sandler
- Pearson Warshaw
- Wilk Auslander
- Berger Montague
- Hagens Berman
- Law Offices of Curtis V. Trinko
- King & Spalding
- Markus & Sheridan
- Pugh Jones
- BoiesBattin
- Hunton Andrews
- Lowther Johnson
- Cafferty Clobes
- Wolf Haldenstein
- Frost Brown
- Day Pitney
- Lowey Dannenberg
- Gardy & Notis
- Taus Cebulash
- Wolf Popper
- Keker Van Nest & Peters
- Kenyon & Kenyon
- Foote Mielke
- Kirby McInerney
- Akin Gump
- Goldman Gruder
- Henrichsen Law Group
- Labaton Keller
Companies
- Humana Inc.
- PRA Health Sciences Inc.
- Impax Laboratories, Inc.
- Medica Health Plans Inc.
- KVK Tech Inc.
- KV Pharmaceutical Co.
- Meijer Inc.
- Noramco Inc.
- Abbott Laboratories
- Allergan PLC
- Rochester Drug Cooperative Inc.
- Purdue Pharma LP
- Boehringer Ingelheim Vetmedica Inc.
- United Food & Commercial Workers International Union
- Aetna Inc.
- United Federation of Teachers
- The Kroger Co.
- Winthrop University Hospital
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 08, 2015
Purdue's Anti-Abuse OxyContin Patent Claims Found Invalid
A New York federal judge on Wednesday ruled that although Amneal Pharmaceuticals LLC infringed Purdue Pharma LP's patent with its generic version of an abuse-resistant variety of the pain medication OxyContin, Purdue's asserted claims are invalid as obvious and indefinite.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login